HomeDRUG • NASDAQ
add
Bright Minds Biosciences Inc
Previous close
$41.04
Day range
$38.24 - $41.99
Year range
$0.93 - $79.02
Market cap
389.12M CAD
Avg Volume
122.14K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 764.46K | -50.70% |
Net income | -749.32K | 50.96% |
Net profit margin | — | — |
Earnings per share | -0.24 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.72M | -15.23% |
Total assets | 6.10M | -11.26% |
Total liabilities | 568.26K | 102.33% |
Total equity | 5.54M | — |
Shares outstanding | 6.99M | — |
Price to book | 33.64 | — |
Return on assets | -30.87% | — |
Return on capital | -32.48% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -749.32K | 50.96% |
Cash from operations | -463.17K | 61.32% |
Cash from investing | — | — |
Cash from financing | -23.56K | -8.83% |
Net change in cash | -470.15K | 66.00% |
Free cash flow | -156.77K | 80.54% |
About
Founded
2017
Website
